Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2003
12/18/2003WO2003104267A1 Kit formulation of a novel peptide c-aca-qalgnqwavghlmnh2
12/18/2003WO2003104266A2 PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR
12/18/2003WO2003104260A2 Pharmaceutical formulation
12/18/2003WO2003103718A2 Intracellular delivery of biological effectors
12/18/2003WO2003103715A1 Modified byrodin 1 with reduced immunogenicity
12/18/2003WO2003103702A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
12/18/2003WO2003103608A2 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003WO2003074558A3 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
12/18/2003WO2003072599A3 Novel chemokine binding peptides capable of modulating the biological activity of chemokines
12/18/2003WO2003033437A3 A method of forming neuraminidase inhibitors by dynamic combinatorial chemistry and compounds obtained
12/18/2003WO2002092781A3 Peptide compounds for counteracting reactive oxygen species and free radicals
12/18/2003WO2002054072A3 Assay to determine efficacy of treatment for mycobacterial infection
12/18/2003US20030232762 Therapeutic treating breast cancer
12/18/2003US20030232761 Novel analogues of glucose-dependent insulinotropic polypeptide
12/18/2003US20030232750 Indolicidin peptide analogues containing at least two basic amino acids; bactericide
12/18/2003CA2790348A1 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin f2.alpha. receptor
12/18/2003CA2489153A1 Modified byrodin 1 with reduced immunogenicity
12/18/2003CA2488937A1 Par-2-activating peptide derivative and pharmaceutical composition using the same
12/18/2003CA2488716A1 Intracellular delivery of biological effectors
12/18/2003CA2488497A1 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003CA2488403A1 Pharmaceutical formulation
12/18/2003CA2488358A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
12/17/2003EP1371983A1 Immunoassay, reagent for immunoassay, and production method of the same
12/17/2003EP1371664A1 Wti modified peptide
12/17/2003EP1370572A2 Mitochondrial membrane permeabilization by hiv-1 vpr and methods of screening
12/17/2003EP1370277A1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1009420B1 Conjugates useful in the treatment of prostate cancer
12/17/2003EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease
12/17/2003CN1462276A Peptide-based compounds
12/17/2003CN1462190A The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy
12/16/2003US6664372 Solution phase synthesis on a soluble homopolymer support by reacting tert-butoxycarbonyl-protected aza-amino acids with bis(pentafluorophenyl) carbonate as carbonyl activation element and coupling to support; combinatorial chemistry
12/16/2003US6664371 Mimetic insect allatostatin analogs for insect control
12/16/2003US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
12/16/2003US6664369 Gonadotropin-releasing hormone (GnRH); Modified GnRH/peptide or cyclic peptide compositions coupled with polymer carriers yield slow-release pharmacologically active molecules having various anticarcinogenic properties
12/16/2003US6664368 Inhibition of nuclear import by backbone cyclic peptide analogs
12/16/2003US6664367 Cyclic peptides containing modified disulfide bonds coupled with a chelating agent capable of complexing with diagnostic and therapeutically useful metal ions, antineoplastic agents, enzymes, coenzymes or toxins
12/16/2003US6664230 Orally administered peptides to ameliorate atherosclerosis
12/16/2003US6664041 Method for preparing a viral extract containing HIV-II RNA
12/16/2003US6663871 Non-replicating or replication- impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition, malaria
12/16/2003US6663868 Heat shock protein-based vaccines and immunotherapies
12/16/2003CA2088788C Peptides that block human immunodeficiency virus infections and methods of use thereof
12/11/2003WO2003102592A2 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures
12/11/2003WO2003102544A2 Assays for measuring matrix metalloproteinase activities
12/11/2003WO2003102538A2 Combinatorial chemical library ii
12/11/2003WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
12/11/2003WO2003102024A1 Combinatorial chemical library i
12/11/2003WO2003102023A1 Tumour-associated peptides that bond to mhc molecules
12/11/2003WO2003102020A2 Carbon nanotube binding peptides
12/11/2003WO2003102015A2 Method and apparatus for detecting and monitoring peptides, and peptides identified therewith
12/11/2003WO2003101393A2 Antibacterial compounds and methods for treating gram positive bacterial infections
12/11/2003WO2003084980A3 Peptide amphiphile solutions and self assembled peptide nanofiber networks
12/11/2003WO2003066079A3 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
12/11/2003WO2003062266A3 Hybrid synthetic method for antimicrobial peptides
12/11/2003WO2003050542A3 Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit
12/11/2003WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/11/2003WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
12/11/2003WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy
12/11/2003WO2003029292A3 Gene regulatory peptides
12/11/2003WO2003025012A3 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals
12/11/2003WO2003022873A9 Organic compounds with biological activity as thrombin inhibitors and use thereof
12/11/2003WO2003011895A8 Compositions and methods for modulation of immune responses
12/11/2003WO2003002730A3 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method
12/11/2003WO2002100885A3 A penta- or tetrapeptide binding to somatostatin receptors and the use of the same
12/11/2003WO2002081506A8 Process for producing trunkamide a compounds
12/11/2003WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
12/11/2003US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors
12/11/2003US20030229200 Useful in treating or preventing obesity
12/11/2003US20030229120 Zinc binding ligand; sustained release of insulin
12/11/2003US20030229034 Drug delivery; nucleic acids; complexing
12/11/2003US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
12/11/2003US20030229021 Antiallergens
12/11/2003US20030229019 Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
12/11/2003US20030229014 Agents and methods for promoting bone growth
12/11/2003US20030229005 Assays for measuring matrix metalloproteinase activities
12/11/2003US20030228700 Provides compounds useful as multifunctional labels in proteomics studies; labels are both lysine specific and increase overall sequence coverage obtained in polypeptide mapping by increasing ionization efficiencies
12/11/2003US20030228660 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/11/2003US20030228622 Lanthanide binding tags
12/11/2003US20030228609 Methods for measuring enzyme activity
12/11/2003US20030228371 Anti-infarction molecules
12/11/2003US20030228365 Pharmaceutical formulation
12/11/2003US20030228353 Wound heraling agents; polypeptide
12/11/2003US20030228274 Immobilization of polypeptide with polyamide-polyether
12/11/2003CA2736974A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736972A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736926A1 Tumour associated peptides that bind to mhc molecules
12/11/2003CA2736921A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2487137A1 Tumour-associated peptides that bind to mhc molecules
12/10/2003EP1368377A2 Modified interferon beta with reduced immunogenicity
12/10/2003EP1368371A2 Transfection complexes
12/10/2003EP1368064A2 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
12/10/2003EP1368053A2 Compositions and methods for treating gonadotrophin related illnesses
12/10/2003EP1368050A2 Virus derived antimicrobial peptides
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367961A2 Peptide scaffold encapsulation of tissue cells and uses thereof
12/10/2003EP0932618B1 Peptide analogues containing a 7-membered lactam ring
12/10/2003EP0824547B1 Anti-fungal peptides
12/10/2003CN1130459C Biological active molecules having potentiating effect on growth hormone biological activity
12/10/2003CN1130373C Process for preparing [3'-deoxy-3'oxox-MeBmt] cyclosporin
12/10/2003CN1130372C 肽衍生物 Peptide derivatives
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 423